1 Min Read
* ENTERED INTO A COLLABORATION WITH MAJOR US BIOTECHNOLOGY COMPANY IN A DEAL WORTH UP TO APPROXIMATELY $250,000 FOR HEMOGENYX Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.